Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Margolin

Showing results (401-410 of 406) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 406 results.
Cancer|October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trialsJoanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
The New England Journal of Medicine|March 1, 2023
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced MelanomaSapna P Patel, Megan Othus, Yuanbin Chen, et al.
Nature|December 19, 2018
Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Nature|March 31, 2012
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Melanoma Management|August 1, 2017
Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversyMariah M Johnson, Sancy A Leachman, Lisa G Aspinwall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanomaP Grover, S N Lo, I Li, et al.
Pageof 41

Showing results (401-410 of 406) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 406 results.
Cancer|October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trialsJoanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
The New England Journal of Medicine|March 1, 2023
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced MelanomaSapna P Patel, Megan Othus, Yuanbin Chen, et al.
Nature|December 19, 2018
Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Nature|March 31, 2012
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Melanoma Management|August 1, 2017
Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversyMariah M Johnson, Sancy A Leachman, Lisa G Aspinwall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanomaP Grover, S N Lo, I Li, et al.
Pageof 41